Changeflow GovPing Healthcare & Life Sciences Analyte sensors and sensing methods featuring d...
Routine Notice Added Final

Analyte sensors and sensing methods featuring dual detection of glucose and ketones

Favicon for changeflow.com USPTO Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO granted Patent US12588844B2 to Abbott Diabetes Care Inc. covering analyte sensors capable of dual detection of glucose and ketones. The patent includes 18 claims for sensors with two working electrodes, one with a ketones-responsive enzyme system and one with a glucose-responsive enzyme, each coated with a membrane of different composition. The invention enables concurrent measurement of both analytes from a single sensor device.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The USPTO granted Abbott Patent US12588844B2 for a dual-function analyte sensor capable of detecting both glucose and ketones simultaneously. The sensor comprises a first working electrode with a ketones-responsive active area using at least two enzymes acting in concert, and a second working electrode with a glucose-responsive active area using a glucose-responsive enzyme. Each active area is overcoated with a membrane of different composition. The patent names six inventors and includes 18 claims covering the sensor architecture and sensing methods.

Patent grants do not create compliance obligations but establish intellectual property rights. For companies developing continuous glucose monitors or ketone sensing devices, this patent may require design modifications to avoid infringement or consideration of licensing arrangements with Abbott. Medical device manufacturers in the diabetes care space should review their product pipelines for potential overlap with the dual-sensing technology described in the 18 claims.

Archived snapshot

Mar 31, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Analyte sensors and sensing methods featuring dual detection of glucose and ketones

Grant US12588844B2 Kind: B2 Mar 31, 2026

Assignee

Abbott Diabetes Care Inc.

Inventors

Benjamin J. Feldman, Tianmei Ouyang, Stephen M. Oja, Lam Tran, Hyun Cho

Abstract

Glucose and ketones may be dysregulated singularly or concurrently in certain physiological conditions and may be advantageously assayed together using an analyte sensor capable of detecting both analytes. Certain analyte sensors capable of dual detection may comprise a first working electrode and a second working electrode, a ketones-responsive active area disposed upon a surface of the first working electrode, a glucose-responsive active area comprising a glucose-responsive enzyme disposed upon a surface of the second working electrode, a membrane having a first portion overcoating the ketones-responsive active area and a second portion overcoating the glucose-responsive active area, in which the first portion and the second portion have different compositions. The ketones-responsive active area comprises an enzyme system comprising at least two enzymes that are capable of acting in concert to facilitate detection of ketones.

CPC Classifications

A61B 5/14865 A61B 5/14532 A61B 5/14546 A61L 31/041

Filing Date

2022-12-19

Application No.

18068072

Claims

18

View original document →

Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12588844B2

Who this affects

Applies to
Medical device makers Healthcare providers Patients
Industry sector
3345 Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!